- Home
- AMWD vs ORIC Comparison
AMWD vs ORIC Comparison
Compare AMWD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMWD | ORIC |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.8M | 837.3M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AMWD | ORIC |
|---|---|---|
| Price | $38.86 | $8.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $59.50 | $19.73 |
| AVG Volume (30 Days) | 259.6K | ★ 1.2M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,709,585,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.29 | $5.51 |
| 52 Week High | $72.16 | $14.93 |
Technical Indicators
Market Signals| Indicator | AMWD | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 37.06 |
| Support Level | $36.48 | $7.90 |
| Resistance Level | $42.58 | $11.22 |
| Average True Range (ATR) | 2.02 | 0.44 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 58.11 | 30.75 |
Price Performance
Historical ComparisonAbout AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.